Applied Therapeutics Inc (APLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 122,197 | 146,484 | 49,898 | 37,457 | 35,616 |
| Other current assets | 253 | 253 | 254 | 0 | 0 |
| TOTAL | $127,572 | $150,906 | $54,386 | $44,488 | $42,821 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 206 | 328 | 447 | 707 | 825 |
| TOTAL | $206 | $328 | $447 | $707 | $825 |
| Total Assets | $127,778 | $151,234 | $54,833 | $45,195 | $43,646 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,683 | 4,019 | 1,742 | 6,005 | 4,687 |
| Accrued Expenses | 10,296 | 14,641 | 15,286 | 12,245 | 16,023 |
| Other current liabilities | 42,192 | 64,937 | 53,725 | 36,763 | 25,992 |
| TOTAL | $55,356 | $83,905 | $71,182 | $55,504 | $47,188 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 30 | 35 | 797 | 735 | 792 |
| TOTAL | $30 | $35 | $797 | $735 | $792 |
| Total Liabilities | $55,386 | $83,940 | $71,979 | $56,239 | $47,980 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 114,846 | 114,267 | 105,887 | 77,229 | 63,124 |
| Common Shares | 11 | 11 | 8 | 7 | 6 |
| Retained earnings | -549,626 | -552,524 | -468,586 | -430,907 | -388,537 |
| TOTAL | $72,392 | $67,294 | $-17,146 | $-11,044 | $-4,334 |
| Total Liabilities And Equity | $127,778 | $151,234 | $54,833 | $45,195 | $43,646 |